17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3.
Although estrogen contributes to glucose homeostasis, its mechanisms remain unclear. To investigate the role of caveolin-3 in estrogen's effects on glucose metabolism. Ovariectomized (OVX) and sham-operated rats, fed with normal chow diet (NCD) or high-calorie diet (HCD), received 17β-estradiol (E(2)) or placebo. Fasting plasma glucose (FPG) was detected and HOMA-IR was calculated. Primary cultured skeletal muscle cells were treated with E(2), in the presence or absence of β-methyl-cyclodextrin and tamoxifen. Glucose consumption and transportation and expression of caveolin-3 were examined. In NCD-fed rats, OVX or E(2) had no effects on FPG or HOMA-IR. In HCD-fed rats, OVX led to the increase of FPG and HOMA-IR, which was attenuated by E(2). In cultured cells, E(2) improved glucose consumption and transportation and enhanced caveolin-3 expression, which were blocked by β-methyl-cyclodextrin and tamoxifen. Caveolin-3 plays an important role in the mechanism by which E(2) attenuates diet-induced glucose intolerance.